mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |